137 related articles for article (PubMed ID: 37316376)
1. Dosimetric and workflow impact of synthetic-MRI use in prostate high-dose-rate brachytherapy.
Podgorsak AR; Venkatesulu BP; Abuhamad M; Harkenrider MM; Solanki AA; Roeske JC; Kang H
Brachytherapy; 2023; 22(5):686-696. PubMed ID: 37316376
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric evaluation of MRI-to-ultrasound automated image registration algorithms for prostate brachytherapy.
Shaaer A; Paudel M; Davidson M; Semple M; Nicolae A; Mendez LC; Chung H; Loblaw A; Tseng CL; Morton G; Ravi A
Brachytherapy; 2020; 19(5):599-606. PubMed ID: 32712028
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
[TBL] [Abstract][Full Text] [Related]
4. Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.
Yang X; Rossi PJ; Jani AB; Mao H; Zhou Z; Curran WJ; Liu T
J Appl Clin Med Phys; 2017 Jan; 18(1):202-210. PubMed ID: 28291925
[TBL] [Abstract][Full Text] [Related]
5. Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.
Yang X; Rossi P; Ogunleye T; Marcus DM; Jani AB; Mao H; Curran WJ; Liu T
Med Phys; 2014 Nov; 41(11):111915. PubMed ID: 25370648
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.
Wang T; Press RH; Giles M; Jani AB; Rossi P; Lei Y; Curran WJ; Patel P; Liu T; Yang X
Br J Radiol; 2019 May; 92(1097):20190089. PubMed ID: 30912959
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
8. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.
Maenhout M; van der Voort van Zyp JRN; Borot de Battisti M; Peters M; van Vulpen M; van den Bosch M; Moerland MA
Brachytherapy; 2018; 17(1):68-77. PubMed ID: 28579419
[TBL] [Abstract][Full Text] [Related]
9. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy.
Shaaer A; Davidson M; Semple M; Nicolae A; Mendez LC; Chung H; Loblaw A; Tseng CL; Morton G; Ravi A
Brachytherapy; 2019; 18(1):95-102. PubMed ID: 30287271
[TBL] [Abstract][Full Text] [Related]
11. Improved tumour control probability with MRI-based prostate brachytherapy treatment planning.
Dinkla AM; Pieters BR; Koedooder K; van Wieringen N; van der Laarse R; van der Grient JN; Rasch CR; Koning CC; Bel A
Acta Oncol; 2013 Apr; 52(3):658-65. PubMed ID: 23282111
[TBL] [Abstract][Full Text] [Related]
12. Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithms.
Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
Radiat Oncol; 2015 Dec; 10():254. PubMed ID: 26666538
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric feasibility of ablative dose escalated focal monotherapy with MRI-guided high-dose-rate (HDR) brachytherapy for prostate cancer.
Hosni A; Carlone M; Rink A; Ménard C; Chung P; Berlin A
Radiother Oncol; 2017 Jan; 122(1):103-108. PubMed ID: 27916416
[TBL] [Abstract][Full Text] [Related]
15. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
[TBL] [Abstract][Full Text] [Related]
16. Catheter position prediction using deep-learning-based multi-atlas registration for high-dose rate prostate brachytherapy.
Lei Y; Wang T; Fu Y; Roper J; Jani AB; Liu T; Patel P; Yang X
Med Phys; 2021 Nov; 48(11):7261-7270. PubMed ID: 34480801
[TBL] [Abstract][Full Text] [Related]
17. Clinical implementation, logistics and workflow guide for MRI image based interstitial HDR brachytherapy for gynecological cancers.
Zhang H; Donnelly ED; Strauss JB; Kang Z; Gopalakrishnan M; Lee PC; Khelashvili G; Nair CK; Lee BH; Sathiaseelan V
J Appl Clin Med Phys; 2019 Nov; 20(11):37-49. PubMed ID: 31600015
[TBL] [Abstract][Full Text] [Related]
18. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
[TBL] [Abstract][Full Text] [Related]
19. Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry.
Sanders JW; Mok H; Hanania AN; Venkatesan AM; Tang C; Bruno TL; Thames HD; Kudchadker RJ; Frank SJ
Radiother Oncol; 2022 Apr; 169():124-131. PubMed ID: 34921895
[TBL] [Abstract][Full Text] [Related]
20. Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer.
Buus S; Rylander S; Hokland S; Søndergaard CS; Pedersen EM; Tanderup K; Bentzen L
Brachytherapy; 2016; 15(4):426-434. PubMed ID: 27220699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
